CDK12 has been found to drive and maintain the growth of cancer cells in a variety of tumours by regulating multiple signalling pathways, including the WNT/β-catenin pathway, MAPK pathway, NF-κB pathway, and DNA damage repair (DDR) pathway3–7. Here, CDK12 is linked to neoplasm.